fda stopping semaglutide ๐จ Moves to Permanently Shut Down Compounded GLP-1s The FDA is taking steps to eliminate large-scale compounding of GLP-1 medications like and tirzepatide, signaling a major shift in how these Some people are overdosing on
Description
It also tells the pituitary to release GH, but through a separate receptor (the ghrelin receptor)

How about a cure for weight stigma that isnt about (us) losing weight? People who are considering these weight loss medications should examine why they feel the need to lose weight

According to Ozempics sponsor Novo Nordisk, worldwide shortages of the only PBS-listed semaglutide-containing drug are expected to continue well into 2024

Strong appetite suppression - usually a feature, sometimes uncomfortable

Retatrutide is undergoing clinical trials and is not available
Brown JC, Pederson RA, Jorpes E, Mutt V
